Preston Robert Tisch Brain Tumor Center at Duke University

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Glioblastoma2 trials

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Bristol-Myers Squibb2 trials

Closed trials

• Completed

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

  NCT02667587· Phase 3· Bristol-Myers Squibb· Source

• Completed

  A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

  NCT02017717· Phase 3· Bristol-Myers Squibb· Source